Vijaya Diagnostic Centre Limited has informed the Exchange regarding a press release dated May 12, 2025, titled "Press Release on Financial Results Q4 FY2025".
VIJAYA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vijaya Diagnostic Centre reported Q4 FY25 revenue of Rs. 1,732.4 million, up 11.6% year-on-year, with organic growth of 13% excluding the PH Diagnostic acquisition. EBITDA rose 9.1% to Rs. 688.6 million, though margins contracted 91 basis points to 39.8% on higher costs. Profit after tax grew modestly at 3.5% to Rs. 346.4 million, with PAT margin falling 156 bps to 20.0%. For full year FY25, revenue grew 24.4% to Rs. 6,813.9 million, EBITDA grew 23.7%, and PAT grew 20.4% to Rs. 1,430.8 million. The company launched 6 new hubs in the past two months across Pune, West Bengal, and Bengaluru, with 3 more West Bengal hubs expected to start in 3–4 months and 2 Tier-2 hubs in AP & Telangana slated for H2 FY26.
Strong full-year topline and PAT growth of 20%+ are positives, but Q4 margin compression and weak PAT growth of just 3.5% may temper near-term investor enthusiasm. Aggressive network expansion into new geographies signals confidence in long-term growth, supporting the structural story.